Pharmacokinetic Comparison Study of Two Nicotine Gum Products
Research type
Research Study
Full title
Comparative, Randomised, Single-Dose, 2-way Crossover Bioavailability Study of Fertin Pharma A/S and McNeil Consumer Healthcare GmbH (Nicorette® Freshmint) 4 mg Nicotine Mint Flavoured Chewing Gum in Healthy Adult Volunteers Under Fasting Conditions
IRAS ID
87568
Sponsor organisation
Fertin Pharma A/S
Eudract number
2011-004107-21
Research summary
The purpose of this study is to compare a new formulation of 4 mg nicotine gum a currently marketed one. The study will find out how much of and the rate at which nicotine gets into and is removed from the body from each of the two formulations.To investigate this, volunteers will chew a single dose of each of the two gum formulations in a random order on 2 separate occasions (i.e. 2 assessment periods) during the study and blood will be assessed and compared for nicotine levels for a period after. There will be an interval of at least 7 days between the two doses.Male and female volunteers who are smokers aged between 18-55 years will take part in this study at one centre in the UK.
REC name
HSC REC A
REC reference
11/NI/0126
Date of REC Opinion
1 Sep 2011
REC opinion
Favourable Opinion